ArticleAmerican journal of cancer research2026
Diagnostic value of mitochondria-related genes in intervertebral disc degeneration associated with spinal metastasis: a Mendelian randomization study.
Article in American journal of cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To identify mitochondria related genes involved in intervertebral disc degeneration (IDD) and to investigate the potential molecular mechanism. The GSE124272 and GSE56081 datasets were used in this study. First, intersecting genes were screened by overlapping key module genes obtained from weighted gene co-expression network analysis (WGCNA) and differentially expressed genes (DEGs). Functional enrichment analyses were performed to explore the functions of intersecting genes. Subsequently, candidate IDD-associated genes were screened using Mendelian randomization (MR) based on the intersecting genes. Thereafter, machine learning algorithm was applied to identify biomarkers, and their diagnostic performance was assessed using receiver operating characteristic (ROC) curves. Single-gene gene set enrichment analysis (GSEA) was utilized to investigate the molecular mechanisms of the identified biomarkers. Meanwhile, correlations between the biomarkers and immune cell infiltration were investigated. In addition, the transcription factor (TF)-mRNA and competing endogenous RNA (ceRNA) networks were constructed. Finally, the mRNA-drug interaction network was established. A total of 827 intersecting genes were screened, and 31 differentially expressed mitochondria-related genes were obtained. Functional enrichment results revealed that these genes were primarily involved in the positive regulation of cytokine production and the cell cycle. Four candidate genes were obtained by MR analysis based on intersecting genes. Finally, two biomarkers (PTGS1 and PPBP) were screened, both of which demonstrated decent diagnostic performance. Single-gene GSEA enrichment results indicated that these two biomarkers were mainly enriched in the ribosome and neuroactive ligand receptor interaction. Correlation analysis showed strongest positive correlation between PTGS1 and mast cells, and the highest negative association between PPBP and activated CD4 T cells. The mRNA-TF regulatory network included 2 mRNAs, 12 TFs, and 15 pairs of regulatory interactions. Furthermore, the ceRNA regulatory network included 2 biomarkers, 45 miRNAs, and 67 long non-coding RNA (lncRNAs). Finally, a total of 70 potential drugs targeting these biomarkers were predicted. In conclusion, PTGS1 and PPBP were identified as key mitochondria-related genes associated with IDD, providing novel insights into the diagnosis and treatment of IDD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.